Forian Inc. expects FY25 revenue of $28-$30mln.
PorAinvest
miércoles, 14 de mayo de 2025, 4:54 pm ET1 min de lectura
FORA--
Key Financial Highlights:
- Revenue: Forian reported $7.1 million in revenue for the quarter ended March 31, 2025, an increase of 45% compared to $4.9 million in the prior year [1].
- Net Loss: The company incurred a net loss of $1.1 million, or $0.04 per share, compared to a net loss of $1.2 million, or $0.04 per share, in the prior year [1].
- Adjusted EBITDA: Adjusted EBITDA was $(0.1) million for the quarter, compared to $0.1 million in the prior year [1].
Operational Milestones:
- Solid Revenue Growth: Forian began the year with its highest quarterly revenue to date, reflecting acquisition impacts, strategic contract renewals, and new logos [1].
- Integration and Investment: The company accelerated contracting and investments and integrated new clinical data feeds, easing upstream data supply disruptions [1].
- Pharmaceutical Expansion: Forian achieved continued growth from pharmaceutical and biotech companies, reflecting increased adoption of its data solutions [1].
- Strategic M&A: The first full quarter integrating Kyber Data Science's platform, predictive analytics, and financial services markets to Forian's business [1].
Full Year 2025 Outlook:
Forian expects revenue to be in the range of $28 to $30 million and adjusted EBITDA to be in the range of $(1.0) to $1.0 million for the year ending December 31, 2025 [1].
References:
[1] https://www.nasdaq.com/press-release/forian-inc-announces-first-quarter-2025-financial-results-2025-05-14
Forian Inc. expects FY25 revenue of $28-$30 million. The company provides data management capabilities and analytics for life sciences, healthcare payers and providers. Its operations consist of subscription and services-based solutions for commercial, Real World Evidence, and market access. Forian also offers machine learning applications for the financial services community.
NEWTOWN, PA - May 14, 2025 (NEWMEDIAWIRE) - Forian Inc. (Nasdaq: FORA), a leading provider of data science-driven information and analytics solutions, today announced its first-quarter 2025 financial results. The company reported a significant increase in revenue and a decrease in net loss compared to the same period last year. Forian's CEO, Max Wygod, highlighted the company's positive momentum and solid assimilation of the Kyber business.Key Financial Highlights:
- Revenue: Forian reported $7.1 million in revenue for the quarter ended March 31, 2025, an increase of 45% compared to $4.9 million in the prior year [1].
- Net Loss: The company incurred a net loss of $1.1 million, or $0.04 per share, compared to a net loss of $1.2 million, or $0.04 per share, in the prior year [1].
- Adjusted EBITDA: Adjusted EBITDA was $(0.1) million for the quarter, compared to $0.1 million in the prior year [1].
Operational Milestones:
- Solid Revenue Growth: Forian began the year with its highest quarterly revenue to date, reflecting acquisition impacts, strategic contract renewals, and new logos [1].
- Integration and Investment: The company accelerated contracting and investments and integrated new clinical data feeds, easing upstream data supply disruptions [1].
- Pharmaceutical Expansion: Forian achieved continued growth from pharmaceutical and biotech companies, reflecting increased adoption of its data solutions [1].
- Strategic M&A: The first full quarter integrating Kyber Data Science's platform, predictive analytics, and financial services markets to Forian's business [1].
Full Year 2025 Outlook:
Forian expects revenue to be in the range of $28 to $30 million and adjusted EBITDA to be in the range of $(1.0) to $1.0 million for the year ending December 31, 2025 [1].
References:
[1] https://www.nasdaq.com/press-release/forian-inc-announces-first-quarter-2025-financial-results-2025-05-14

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios